Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Novartis Pharmaceuticals · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
interstitial-lung-disease
idiopathic inflammatory myopathies, chimeric antigen receptor t cells (car-t), rapcabtagene autoleucel, idiopathic inflammatory myopathies (iim), dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, interstitial lung disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 827901
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.